Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte CorpfiledCriticalIncyte Corp
Publication of ECSP088650ApublicationCriticalpatent/ECSP088650A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a los inhibidores de la 11-ß-hidroxil-esteroide deshidrogenasa tipo 1 y las composiciones farmacéuticas de la misma. Los compuestos de la invención pueden ser útiles en el tratamiento de diversas enfermedades asociadas con la expresión o actividad de la 11-ß-hidroxil-esteroide deshidrogenasa tipo l, como es ejemplificado por la fórmula (I).The present invention relates to 11-β-hydroxyl-steroid dehydrogenase type 1 inhibitors and pharmaceutical compositions thereof. The compounds of the invention may be useful in the treatment of various diseases associated with the expression or activity of 11-β-hydroxyl-steroid dehydrogenase type l, as exemplified by formula (I).
ECSP0886502006-01-312008-07-28
AMIDO COMPOUNDS AND ITS USE AS PHARMACEUTICAL PRODUCTS
ECSP088650A
(en)
Compounds derived from 1-oxo-2,3-dihydro-1h-isoindolin-5-yl) -isoxazol-3-carboxamide, enhancers of mglur2; pharmaceutical composition; and its use to relieve symptoms or reduce the appearance of symptoms of ezchizophrenia or anxiety.